DAS UK partners with Maxima on clinical negligence/personal injury scheme

DAS UK Group, a UK’s provider of ATE insurance, and Maxima, the litigation funding and risk solutions provider, have launched Optimise a new clinical negligence/personal injury scheme aimed specifically at smaller legal practices.

Launched in line with the government’s highly anticipated motor legal reforms, Optimise is the first scheme in the UK to offer any legal firm (including sole practitioners and small departments), that writes clinical negligence or personal injury cases, a full delegated authority scheme. The required case volume threshold is also much lower than that for similar schemes.

Brokered through Maxima on behalf of DAS UK, Optimise will cover the widest range of personal injury cases including specialist areas such as sexual abuse, asbestos-related diseases and animal act cases. It will also cover a wide range of clinical negligence cases including specialist areas such as dental negligence.

Vanessa Andrews, head of ATE Operations at Maxima, said: “We recognise that there are smaller firms with good quality, but lower volumes, of cases that should not lose out on the benefits of a scheme. Most insurers only offer schemes now in these sectors, to make it viable to offer after the event insurance. So we hope this is a welcome new addition to the market and well received by firms that have been looking for something like this, having previously been rejected or finding themselves currently without a provider.”

John Durbin, sales & business development manager, DAS UK Group, said: “We are obviously aware that certain insurers have pulled out of the market, meaning some firms who would have been able to access ATE for clinical negligence and personal injury will no longer have the benefit of their scheme or ‘one off’ applications being underwritten. Therefore, we felt it was the right time to assist smaller firms who still specialise in personal injury and clinical negligence.”

Did you get value from this story?  Sign up to our free daily newsletters and get stories like this sent straight to your inbox.